Livzon Pharma Appoints Ran Yongmei to Strategy Committee, Tang Yanggang to Nomination Committee

Bulletin Express03-24

Livzon Pharmaceutical Group Inc. (LIVZON PHARMA) announced that, effective 24 March 2026, two board-level committee changes have taken effect:

• Strategy Committee: Employee representative director Ms. Ran Yongmei has joined the committee. • Nomination Committee: Executive director and vice chairman Mr. Tang Yanggang has been appointed as a committee member.

According to the filing, these are the only alterations to the board’s committee structure. The remainder of the board and its committees remain unchanged. Livzon Pharma’s board now consists of one executive director, three non-executive directors, one employee representative director, and four independent non-executive directors.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment